7Baggers
 Solid Biosciences stock rises after licensing next-generation capsid  Investing.com Mon, 17 Nov 2025 18:09:10 GMT
 Andelyn Biosciences Signs Licensing Agreement with Solid Biosciences  Contract Pharma Mon, 17 Nov 2025 16:26:53 GMT
 Solid Biosciences Licenses Use of Next-Generation Capsid AAV-SLB101 to Andelyn Biosciences  Genetic Engineering and Biotechnology News Mon, 17 Nov 2025 15:00:39 GMT
 Solid Biosciences (SLDB) Partners with Andelyn Biosciences for G  GuruFocus Mon, 17 Nov 2025 13:49:12 GMT
 Solid Biosciences licenses next-generation AAV capsid to Andelyn  Investing.com Mon, 17 Nov 2025 13:25:01 GMT
 Solid Biosciences Announces Licensing Agreement with  GlobeNewswire Mon, 17 Nov 2025 13:00:00 GMT
 Director’s Stock Sale at Solid Biosciences Raises Eyebrows  TipRanks Fri, 14 Nov 2025 03:40:55 GMT
 Solid Biosciences director Ganot sells $13,505 in stock  Investing.com Thu, 13 Nov 2025 21:55:16 GMT
 published on: 2025-11-13 11:56:56  newser.com Thu, 13 Nov 2025 17:56:56 GMT
 published on: 2025-11-13 00:52:23  newser.com Thu, 13 Nov 2025 06:52:23 GMT
 published on: 2025-11-12 01:14:25  newser.com Wed, 12 Nov 2025 07:14:25 GMT
 Solid Biosciences to Participate at Upcoming Investor Conferences  GlobeNewswire Tue, 11 Nov 2025 13:00:00 GMT
 published on: 2025-11-11 06:18:12  newser.com Tue, 11 Nov 2025 12:18:12 GMT
 published on: 2025-11-07 00:47:57  newser.com Fri, 07 Nov 2025 06:47:57 GMT
 sldb gains innovation passport for gene therapy in uk  GuruFocus Thu, 06 Nov 2025 13:42:21 GMT
 sldb: citigroup lowers price target but maintains buy rating | s  GuruFocus Thu, 06 Nov 2025 11:46:11 GMT
 sldb: citigroup lowers price target but maintains buy rating | s  GuruFocus Wed, 05 Nov 2025 21:32:52 GMT
 JP Morgan Adjusts Price Target for Solid Biosciences (SLDB) | SL  GuruFocus Wed, 05 Nov 2025 20:40:46 GMT
 solid biosciences price target lowered to $14 from $16 at citi  TipRanks Wed, 05 Nov 2025 13:09:08 GMT
 published on: 2025-11-05 05:44:16  newser.com Wed, 05 Nov 2025 11:44:16 GMT
 chardan capital maintains buy rating and price target on sldb |  GuruFocus Tue, 04 Nov 2025 14:05:33 GMT
 published on: 2025-11-04 02:33:46  newser.com Tue, 04 Nov 2025 08:33:46 GMT
 solid biosciences reports q3 2025 results and clinical progress  TipRanks Tue, 04 Nov 2025 04:13:09 GMT
 published on: 2025-11-03 21:39:09  newser.com Tue, 04 Nov 2025 03:39:09 GMT
 solid biosciences (sldb) reports promising interim data on duche  GuruFocus Mon, 03 Nov 2025 22:19:51 GMT
 solid biosciences reports q3 eps (48c), consensus (44c)  TipRanks Mon, 03 Nov 2025 21:38:45 GMT
 Solid Biosciences Reports Third Quarter 2025 Financial  GlobeNewswire Mon, 03 Nov 2025 08:00:00 GMT
 Solid Biosciences Reports Q3 2025 Results and Clinical Progress  TipRanks Mon, 03 Nov 2025 08:00:00 GMT
 Solid Biosciences Reports Positive Interim Data on SGT-003  TipRanks Mon, 03 Nov 2025 08:00:00 GMT

Solid Biosciences Inc
(NASDAQ:SLDB) 

SLDB stock logo

Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expre...

Founded: 2013
Full Time Employees: 121
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends